Skip to main content

Table 1 Overview of measures and corresponding measurement time points

From: Mindfulness as a complementary intervention in the treatment of overweight and obesity in primary health care: study protocol for a randomised controlled trial

Measure Target concept Baseline T1 T2
BES Binge eating x x x
BPAAT Physical activity x x x
DEBQ Food style x x x
EAT-26 Presence of abnormal eating patterns x x x
HADS Anxiety and depression symptoms x x x
MAAS Mindfulness skills x x x
FFQ Food Frequency Questionnaire x x x
SCS Self-compassion x x x
Transtheoretical Model Behaviour change x x x
Feasibility Questionnaire Feasibility of intervention   x  
Adverse effects questionnaire Occurrence adverse effects   x x
Amount of weekly practices Adherence to practice   x x
Anthropometry Change in weight x x x
Basal metabolic rate Basal metabolism x x x
Body composition Fat mass and lean mass x x x
BDNF Brain-derived neurotrophic factor x x x
Cortisol serum Stress x x x
Fasting blood glucose Glycaemic control x x x
HbA1c Haemoglobin A1c x x x
Insulin Insulin x x x
US-CRP Ultra-sensitive C-reactive protein x x x
Total cholesterol, fractions and TGL Lipid profile x x x
Alpha-1-glycoprotein Inflammatory process x x x
Focus group Qualitative analysis   x x
  1. Abbreviations: BES Binge Eating Scale, BPAAT Brief Physical Activity Assessment Tool, DEBQ Dutch Food Behaviour Questionnaire, EAT-26 Eating Attitude Test, FFQ Food Frequency Questionnaire, HADS Hospital Anxiety and Depression Scale HbA1c glycated haemoglobin, MAAS Mindful Attention Awareness Scale, SCS Self-Compassion Scale, T1 8 or 10 weeks post-intervention (TAU, TAU + MBHP, TAU + MB-EAT), T2 3 months post-intervention (TAU, TAU + MBHP, TAU + MB-EAT), US-CRP Ultra-sensitive C-reactive protein, BDNF Brain-derived neurotrophic factor, TGL Triglycerides